tiprankstipranks
Xenetic Biosciences Shares Insights on Oncology Platform
Company Announcements

Xenetic Biosciences Shares Insights on Oncology Platform

Xenetic Biosciences (XBIO) has released an update.

Don't Miss Our Christmas Offers:

Xenetic Biosciences, Inc. recently showcased a virtual investor event video featuring their Chief Scientific Officer, Dr. Curis Lockshin, who discussed exciting preclinical data from their DNase I oncology platform. Interested parties can easily access this insightful video via the provided link to gain a deeper understanding of the company’s innovative approach to cancer treatment. This resource offers a valuable glimpse into Xenetic’s cutting-edge research and development efforts in the field of oncology.

For further insights into XBIO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyXenetic extends research collaboration with University of Virginia
TheFlyXenetic enters clinical trial services agreement with PeriNess
TheFlyXenetic presents preclinical data on DNase I with CAR T cells in murine model
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App